The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Dengue Rapid Test-Global Market Insights and Sales Trends 2024
Synopsis
The global Dengue Rapid Test market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dengue Rapid Test in various end use industries. The expanding demands from the Medical Hospitals, Diagnostic Centers and Others,, are propelling Dengue Rapid Test market. ELISA-Based Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NS1-Rapid Dengue Test segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dengue Rapid Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dengue Rapid Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dengue Rapid Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dengue Rapid Test sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dengue Rapid Test covered in this report include Maternova, Abbott Laboratories, OriGene Technologies, Euroimmun AG, InBios International, NovaTec Immundiagnostica GmbH, Abnova Corporation, Quest Diagnostics and DiaSorin Group, etc.
The global Dengue Rapid Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Maternova
Abbott Laboratories
OriGene Technologies
Euroimmun AG
InBios International
NovaTec Immundiagnostica GmbH
Abnova Corporation
Quest Diagnostics
DiaSorin Group
Roche Molecular Systems
Certest Biotec S.L.
Thermo Fisher Scientific
Global Dengue Rapid Test market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dengue Rapid Test market, Segment by Type:
ELISA-Based Test
NS1-Rapid Dengue Test
RT-PCR Amplification Test
Dengue IgG/IgM Rapid Test
Others
Global Dengue Rapid Test market, by Application
Medical Hospitals
Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Dengue Rapid Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Dengue Rapid Test market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dengue Rapid Test in various end use industries. The expanding demands from the Medical Hospitals, Diagnostic Centers and Others,, are propelling Dengue Rapid Test market. ELISA-Based Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NS1-Rapid Dengue Test segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dengue Rapid Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dengue Rapid Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dengue Rapid Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dengue Rapid Test sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dengue Rapid Test covered in this report include Maternova, Abbott Laboratories, OriGene Technologies, Euroimmun AG, InBios International, NovaTec Immundiagnostica GmbH, Abnova Corporation, Quest Diagnostics and DiaSorin Group, etc.
The global Dengue Rapid Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Maternova
Abbott Laboratories
OriGene Technologies
Euroimmun AG
InBios International
NovaTec Immundiagnostica GmbH
Abnova Corporation
Quest Diagnostics
DiaSorin Group
Roche Molecular Systems
Certest Biotec S.L.
Thermo Fisher Scientific
Global Dengue Rapid Test market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dengue Rapid Test market, Segment by Type:
ELISA-Based Test
NS1-Rapid Dengue Test
RT-PCR Amplification Test
Dengue IgG/IgM Rapid Test
Others
Global Dengue Rapid Test market, by Application
Medical Hospitals
Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Dengue Rapid Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Dengue Rapid Test
1.1 Dengue Rapid Test Market Overview
1.1.1 Dengue Rapid Test Product Scope
1.1.2 Dengue Rapid Test Market Status and Outlook
1.2 Global Dengue Rapid Test Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Dengue Rapid Test Market Size by Region (2018-2029)
1.4 Global Dengue Rapid Test Historic Market Size by Region (2018-2023)
1.5 Global Dengue Rapid Test Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Dengue Rapid Test Market Size (2018-2029)
1.6.1 North America Dengue Rapid Test Market Size (2018-2029)
1.6.2 Europe Dengue Rapid Test Market Size (2018-2029)
1.6.3 Asia-Pacific Dengue Rapid Test Market Size (2018-2029)
1.6.4 Latin America Dengue Rapid Test Market Size (2018-2029)
1.6.5 Middle East & Africa Dengue Rapid Test Market Size (2018-2029)
2 Dengue Rapid Test Market by Type
2.1 Introduction
2.1.1 ELISA-Based Test
2.1.2 NS1-Rapid Dengue Test
2.1.3 RT-PCR Amplification Test
2.1.4 Dengue IgG/IgM Rapid Test
2.1.5 Others
2.2 Global Dengue Rapid Test Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Dengue Rapid Test Historic Market Size by Type (2018-2023)
2.2.2 Global Dengue Rapid Test Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Dengue Rapid Test Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Dengue Rapid Test Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Dengue Rapid Test Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Dengue Rapid Test Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Dengue Rapid Test Revenue Breakdown by Type (2018-2029)
3 Dengue Rapid Test Market Overview by Application
3.1 Introduction
3.1.1 Medical Hospitals
3.1.2 Diagnostic Centers
3.1.3 Others
3.2 Global Dengue Rapid Test Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Dengue Rapid Test Historic Market Size by Application (2018-2023)
3.2.2 Global Dengue Rapid Test Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Dengue Rapid Test Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Dengue Rapid Test Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Dengue Rapid Test Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Dengue Rapid Test Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Dengue Rapid Test Revenue Breakdown by Application (2018-2029)
4 Dengue Rapid Test Competition Analysis by Players
4.1 Global Dengue Rapid Test Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dengue Rapid Test as of 2022)
4.3 Date of Key Players Enter into Dengue Rapid Test Market
4.4 Global Top Players Dengue Rapid Test Headquarters and Area Served
4.5 Key Players Dengue Rapid Test Product Solution and Service
4.6 Competitive Status
4.6.1 Dengue Rapid Test Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Maternova
5.1.1 Maternova Profile
5.1.2 Maternova Main Business
5.1.3 Maternova Dengue Rapid Test Products, Services and Solutions
5.1.4 Maternova Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.1.5 Maternova Recent Developments
5.2 Abbott Laboratories
5.2.1 Abbott Laboratories Profile
5.2.2 Abbott Laboratories Main Business
5.2.3 Abbott Laboratories Dengue Rapid Test Products, Services and Solutions
5.2.4 Abbott Laboratories Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Laboratories Recent Developments
5.3 OriGene Technologies
5.3.1 OriGene Technologies Profile
5.3.2 OriGene Technologies Main Business
5.3.3 OriGene Technologies Dengue Rapid Test Products, Services and Solutions
5.3.4 OriGene Technologies Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.3.5 Euroimmun AG Recent Developments
5.4 Euroimmun AG
5.4.1 Euroimmun AG Profile
5.4.2 Euroimmun AG Main Business
5.4.3 Euroimmun AG Dengue Rapid Test Products, Services and Solutions
5.4.4 Euroimmun AG Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.4.5 Euroimmun AG Recent Developments
5.5 InBios International
5.5.1 InBios International Profile
5.5.2 InBios International Main Business
5.5.3 InBios International Dengue Rapid Test Products, Services and Solutions
5.5.4 InBios International Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.5.5 InBios International Recent Developments
5.6 NovaTec Immundiagnostica GmbH
5.6.1 NovaTec Immundiagnostica GmbH Profile
5.6.2 NovaTec Immundiagnostica GmbH Main Business
5.6.3 NovaTec Immundiagnostica GmbH Dengue Rapid Test Products, Services and Solutions
5.6.4 NovaTec Immundiagnostica GmbH Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.6.5 NovaTec Immundiagnostica GmbH Recent Developments
5.7 Abnova Corporation
5.7.1 Abnova Corporation Profile
5.7.2 Abnova Corporation Main Business
5.7.3 Abnova Corporation Dengue Rapid Test Products, Services and Solutions
5.7.4 Abnova Corporation Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.7.5 Abnova Corporation Recent Developments
5.8 Quest Diagnostics
5.8.1 Quest Diagnostics Profile
5.8.2 Quest Diagnostics Main Business
5.8.3 Quest Diagnostics Dengue Rapid Test Products, Services and Solutions
5.8.4 Quest Diagnostics Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.8.5 Quest Diagnostics Recent Developments
5.9 DiaSorin Group
5.9.1 DiaSorin Group Profile
5.9.2 DiaSorin Group Main Business
5.9.3 DiaSorin Group Dengue Rapid Test Products, Services and Solutions
5.9.4 DiaSorin Group Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.9.5 DiaSorin Group Recent Developments
5.10 Roche Molecular Systems
5.10.1 Roche Molecular Systems Profile
5.10.2 Roche Molecular Systems Main Business
5.10.3 Roche Molecular Systems Dengue Rapid Test Products, Services and Solutions
5.10.4 Roche Molecular Systems Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.10.5 Roche Molecular Systems Recent Developments
5.11 Certest Biotec S.L.
5.11.1 Certest Biotec S.L. Profile
5.11.2 Certest Biotec S.L. Main Business
5.11.3 Certest Biotec S.L. Dengue Rapid Test Products, Services and Solutions
5.11.4 Certest Biotec S.L. Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.11.5 Certest Biotec S.L. Recent Developments
5.12 Thermo Fisher Scientific
5.12.1 Thermo Fisher Scientific Profile
5.12.2 Thermo Fisher Scientific Main Business
5.12.3 Thermo Fisher Scientific Dengue Rapid Test Products, Services and Solutions
5.12.4 Thermo Fisher Scientific Dengue Rapid Test Revenue (US$ Million) & (2018-2023)
5.12.5 Thermo Fisher Scientific Recent Developments
6 North America
6.1 North America Dengue Rapid Test Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Dengue Rapid Test Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Dengue Rapid Test Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Dengue Rapid Test Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Dengue Rapid Test Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Dengue Rapid Test Market Dynamics
11.1 Dengue Rapid Test Industry Trends
11.2 Dengue Rapid Test Market Drivers
11.3 Dengue Rapid Test Market Challenges
11.4 Dengue Rapid Test Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
